Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126309282 | 12630928 | 2 | F | 2010 | 20160502 | 20160808 | 20160808 | PER | US-BEH-2011027430 | CSL BEHRING | 67.53 | YR | F | Y | 0.00000 | 20160804 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126309282 | 12630928 | 1 | PS | HIZENTRA | HUMAN IMMUNOGLOBULIN G | 1 | Subcutaneous | Y | 0 | 50 | ML | /wk | |||||||
| 126309282 | 12630928 | 2 | SS | HIZENTRA | HUMAN IMMUNOGLOBULIN G | 1 | Y | 4323800002 | 0 | ||||||||||
| 126309282 | 12630928 | 3 | SS | HIZENTRA | HUMAN IMMUNOGLOBULIN G | 1 | Y | 4349300018 | 0 | ||||||||||
| 126309282 | 12630928 | 4 | SS | VOLTAREN | DICLOFENAC SODIUM | 1 | Topical | 0 | QID | ||||||||||
| 126309282 | 12630928 | 5 | C | LASIX | FUROSEMIDE | 1 | Oral | 0 | 40 | MG | QD | ||||||||
| 126309282 | 12630928 | 6 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Oral | 0 | |||||||||||
| 126309282 | 12630928 | 7 | C | COZAAR | LOSARTAN POTASSIUM | 1 | 0 | 50 | MG | BID | |||||||||
| 126309282 | 12630928 | 8 | C | WELLBUTRIN | BUPROPION HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126309282 | 12630928 | 9 | C | CARTIA XT | DILTIAZEM HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126309282 | 12630928 | 10 | C | VITAMIN D | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
| 126309282 | 12630928 | 11 | C | NEURONTIN | GABAPENTIN | 1 | 0 | ||||||||||||
| 126309282 | 12630928 | 12 | C | LANTUS | INSULIN GLARGINE | 1 | 0 | ||||||||||||
| 126309282 | 12630928 | 13 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | 0 | ||||||||||||
| 126309282 | 12630928 | 14 | C | STARLIX | NATEGLINIDE | 1 | 0 | ||||||||||||
| 126309282 | 12630928 | 15 | C | REQUIP | ROPINIROLE HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126309282 | 12630928 | 1 | Immunodeficiency common variable |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126309282 | 12630928 | OT |
| 126309282 | 12630928 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126309282 | 12630928 | Acidosis | |
| 126309282 | 12630928 | Acute kidney injury | |
| 126309282 | 12630928 | Asthenia | |
| 126309282 | 12630928 | Blood creatinine abnormal | |
| 126309282 | 12630928 | Dehydration | |
| 126309282 | 12630928 | Fatigue | |
| 126309282 | 12630928 | Hyperkalaemia | |
| 126309282 | 12630928 | Malaise |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126309282 | 12630928 | 1 | 20100831 | 0 | ||
| 126309282 | 12630928 | 2 | 201012 | 0 | ||
| 126309282 | 12630928 | 3 | 201012 | 0 |